Echo Therapeutics Company Profile (NASDAQ:ECTE)

About Echo Therapeutics (NASDAQ:ECTE)

Echo Therapeutics logoEcho Therapeutics, Inc. is a medical device company. The Company is engaged in developing a non-invasive, wireless continuous glucose monitoring (CGM) system with use in the wearable-health consumer market, diabetes outpatient market and in the hospital setting. The Company operates through the development of transdermal skin permeation and diagnostic medical devices segment. The Company has also developed its needle-free skin preparation device as a platform technology that allows for enhanced skin permeation enabling extraction of analytes, such as glucose, enhanced delivery of topical pharmaceuticals and other applications. The CGM System includes a skin preparation device, transdermal glucose sensor, battery and wireless transmitter. The Company has conducted several human feasibility clinical studies with its CGM System in healthy subjects, diabetics and critically ill patients, as well as a clinical study at several hospitals in the United States.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drug Manufacturers - Major
  • Sub-Industry: N/A
  • Symbol: NASDAQ:ECTE
  • CUSIP: N/A
  • Web: www.echotx.com
Average Prices:
  • 50 Day Moving Avg: $0.03
  • 200 Day Moving Avg: $0.05
  • 52 Week Range: $0.01 - $0.45
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -0.01
  • P/E Growth: 0.000
Sales & Book Value:
  • Annual Revenue: N/A
  • Price / Sales: N/A
  • Book Value: ($0.55) per share
  • Price / Book: -0.03
Profitability:
  • EBITDA: ($5,180,000.00)
  • Return on Assets: 216.11%
Misc:
  • Average Volume: 15,962 shs.
  • Beta: 1.14
  • Short Ratio: 3.4
 

Frequently Asked Questions for Echo Therapeutics (NASDAQ:ECTE)

What is Echo Therapeutics' stock symbol?

Echo Therapeutics trades on the NASDAQ under the ticker symbol "ECTE."

How were Echo Therapeutics' earnings last quarter?

Echo Therapeutics Inc (NASDAQ:ECTE) posted its quarterly earnings results on Friday, August, 12th. The company reported ($0.82) earnings per share for the quarter. During the same period in the prior year, the firm earned ($0.97) earnings per share. View Echo Therapeutics' Earnings History.

When will Echo Therapeutics make its next earnings announcement?

Echo Therapeutics is scheduled to release their next quarterly earnings announcement on Wednesday, November, 15th 2017. View Earnings Estimates for Echo Therapeutics.

Who are some of Echo Therapeutics' key competitors?

Who are Echo Therapeutics' key executives?

Echo Therapeutics' management team includes the folowing people:

  • Alan W. Schoenbart CPA, Chief Executive Officer, Chief Financial Officer, Secretary, Director

How do I buy Echo Therapeutics stock?

Shares of Echo Therapeutics can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Echo Therapeutics' stock price today?

One share of Echo Therapeutics stock can currently be purchased for approximately $0.02.


MarketBeat Community Rating for Echo Therapeutics (NASDAQ ECTE)
Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  65 (Vote Outperform)
Underperform Votes:  52 (Vote Underperform)
Total Votes:  117
MarketBeat's community ratings are surveys of what our community members think about Echo Therapeutics and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Echo Therapeutics (NASDAQ:ECTE) (How are Consensus Ratings Calculated?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A
Consensus Price Target History for Echo Therapeutics (NASDAQ:ECTE)
Price Target History for Echo Therapeutics (NASDAQ:ECTE)
Analysts' Ratings History for Echo Therapeutics (NASDAQ:ECTE)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History for Echo Therapeutics (NASDAQ:ECTE)
Earnings by Quarter for Echo Therapeutics (NASDAQ:ECTE)
Earnings History by Quarter for Echo Therapeutics (NASDAQ ECTE)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/15/2017        
8/12/2016Q2($0.82)ViewN/AView Earnings Details
5/20/2016Q1($0.23)ViewN/AView Earnings Details
11/16/2015Q3 15($0.16)ViewN/AView Earnings Details
8/14/2015Q215($0.97)ViewN/AView Earnings Details
5/15/2015Q1 15($0.72)ViewN/AView Earnings Details
11/19/2014Q314($0.31)($0.43)$19.11 millionViewN/AView Earnings Details
8/14/2014Q214($0.23)($0.31)$22.56 million$19.10 millionViewN/AView Earnings Details
5/9/2014Q114($0.26)($0.23)$0.02 million$0.02 millionViewN/AView Earnings Details
3/27/2014Q413($0.36)($0.35)$0.02 million($0.04) millionViewN/AView Earnings Details
11/7/2013($0.56)($0.48)ViewN/AView Earnings Details
8/8/2013Q2 2013($0.81)($0.51)$10.00 million$22.56 millionViewN/AView Earnings Details
5/10/2013Q1 2013($0.10)($0.13)$0.01 millionViewN/AView Earnings Details
11/8/2012Q312($0.09)($0.11)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Echo Therapeutics (NASDAQ:ECTE)
Current Year EPS Consensus Estimate: $-1.190 EPS
Next Year EPS Consensus Estimate: $-1.700 EPS

Dividends

Dividend History for Echo Therapeutics (NASDAQ:ECTE)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Echo Therapeutics (NASDAQ:ECTE)
Insider Trades by Quarter for Echo Therapeutics (NASDAQ:ECTE)
Insider Trades by Quarter for Echo Therapeutics (NASDAQ:ECTE)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/20/2015Alan Wayne SchoenbartCFOBuy2,500$1.44$3,600.00View SEC Filing  
5/20/2015Scott Wayne HollanderCEOBuy8,000$1.48$11,840.00View SEC Filing  
6/30/2014Mark NordlichtMajor ShareholderBuy65,739$2.20$144,625.80View SEC Filing  
6/26/2014Mark NordlichtMajor ShareholderBuy17,300$2.20$38,060.00View SEC Filing  
6/24/2014Mark NordlichtMajor ShareholderBuy16,961$2.20$37,314.20View SEC Filing  
12/10/2013Mark Nordlichtmajor shareholderBuy69,569$2.75$191,314.75View SEC Filing  
3/22/2013Robert F DomanDirectorBuy15,000$0.80$12,000.00View SEC Filing  
3/21/2013William GriecoDirectorBuy30,000$0.76$22,800.00View SEC Filing  
8/23/2012James Francis SmithDirectorBuy20,000$1.47$29,400.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Echo Therapeutics (NASDAQ:ECTE)
Latest Headlines for Echo Therapeutics (NASDAQ:ECTE)
Source:
DateHeadline
finance.yahoo.com logo/C O R R E C T I O N -- Manchester Management LLC/
finance.yahoo.com - October 5 at 9:59 AM
finance.yahoo.com logoEcho Therapeutics Announces Federal Court's Denial Of Preliminary Injunction And Lifting Of Temporary Restraining Order
finance.yahoo.com - October 5 at 9:59 AM
finance.yahoo.com logoEcho Therapeutics Announces Dismissal of Federal Court Action
finance.yahoo.com - October 5 at 9:59 AM
americanbankingnews.com logoEcho Therapeutics (NASDAQ:ECTE) vs. Tonix Pharmaceuticals Holding Corp. (TNXP) Head-To-Head Comparison
www.americanbankingnews.com - July 23 at 10:20 AM
americanbankingnews.com logoTonix Pharmaceuticals Holding Corp. (TNXP) versus Echo Therapeutics (ECTE) Head-To-Head Analysis
www.americanbankingnews.com - July 22 at 8:02 AM
americanbankingnews.com logoAnalyzing Echo Therapeutics (ECTE) & Tonix Pharmaceuticals Holding Corp. (TNXP)
www.americanbankingnews.com - July 20 at 10:16 PM
americanbankingnews.com logoFinancial Contrast: Echo Therapeutics (ECTE) & Tonix Pharmaceuticals Holding Corp. (TNXP)
www.americanbankingnews.com - July 16 at 2:20 PM
americanbankingnews.com logoReviewing Echo Therapeutics (ECTE) and Tonix Pharmaceuticals Holding Corp. (TNXP)
www.americanbankingnews.com - July 11 at 7:36 AM
americanbankingnews.com logoHead to Head Contrast: Tonix Pharmaceuticals Holding Corp. (TNXP) versus Echo Therapeutics (ECTE)
www.americanbankingnews.com - July 7 at 8:07 AM
americanbankingnews.com logoCritical Review: Echo Therapeutics (NASDAQ:ECTE) and Tonix Pharmaceuticals Holding Corp. (TNXP)
www.americanbankingnews.com - July 6 at 4:26 PM
americanbankingnews.com logoFinancial Analysis: Tonix Pharmaceuticals Holding Corp. (TNXP) and Echo Therapeutics (ECTE)
www.americanbankingnews.com - July 6 at 7:42 AM
biz.yahoo.com logoECHO THERAPEUTICS, INC. Files SEC form 8-K, Other Events
biz.yahoo.com - December 14 at 5:53 PM
us.rd.yahoo.com logo2:28 pm Echo Therapeutics announces they were informed by BDO USA that BDO was resigning as the co's independent registered public accounting firm
us.rd.yahoo.com - December 1 at 10:00 PM
biz.yahoo.com logoECHO THERAPEUTICS, INC. Files SEC form 8-K, Creation of a Direct Financial Obligation or an Obligation under an Off-B
biz.yahoo.com - October 19 at 5:07 PM
rttnews.com logoEARNINGS SUMMARY: Details of Echo Therapeutics, Inc Q2 Earnings Report
www.rttnews.com - August 13 at 4:42 PM
rttnews.com logoEcho Fails The Test, OREX To Effect Reverse Split, PFE's S-TRAC Study Hits Goal
www.rttnews.com - July 11 at 9:34 AM
feeds.benzinga.com logoEcho Therapeutics Gets Fresh Patent For Non-Invasive Sensing Technology
feeds.benzinga.com - June 22 at 9:30 AM
biz.yahoo.com logoECHO THERAPEUTICS, INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financia
biz.yahoo.com - June 3 at 10:13 AM
feeds.benzinga.com logoEcho Therapeutics Says It's In Final Stage Of Clinical Research Organization Selection
feeds.benzinga.com - June 2 at 10:09 AM
prnewswire.com logoEcho Therapeutics, Inc. Announces First Quarter 2016 Financial Results - PR Newswire (press release)
www.prnewswire.com - May 20 at 3:36 PM
rttnews.com logoEARNINGS SUMMARY: Details of Echo Therapeutics, Inc Q1 Earnings Report
www.rttnews.com - May 20 at 3:36 PM
prnewswire.com logoEcho Therapeutics Announces Successful Software Transfer to its Strategic Partner, MTIA - PR Newswire (press release)
www.prnewswire.com - May 17 at 3:37 PM
biz.yahoo.com logoECHO THERAPEUTICS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
biz.yahoo.com - April 14 at 3:38 PM
biz.yahoo.com logoECHO THERAPEUTICS, INC. Files SEC form 10-K, Annual Report
biz.yahoo.com - March 30 at 4:59 PM
feeds.benzinga.com logoEcho Therapeutics Says Nasdaq Granted Request to Remain Listed
feeds.benzinga.com - March 10 at 1:17 PM
biz.yahoo.com logoEcho Therapeutics, Inc. (ECTE)
biz.yahoo.com - February 25 at 8:55 PM
biz.yahoo.com logoECHO THERAPEUTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financia
biz.yahoo.com - February 3 at 6:07 AM
biz.yahoo.com logoECHO THERAPEUTICS, INC. Files SEC form 8-K, Unregistered Sale of Equity Securities, Material Modification to Rights o
biz.yahoo.com - September 30 at 1:30 PM

Social

Chart

Echo Therapeutics (ECTE) Chart for Friday, October, 20, 2017

This page was last updated on 10/20/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.